We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+23.95%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.74B
AUM Growth
+$946M
Cap. Flow
+$105M
Cap. Flow %
1.56%
Top 10 Hldgs %
63.65%
Holding
393
New
188
Increased
79
Reduced
42
Closed
65

Top Buys

Rank Stock Value
1
XRAY icon
Dentsply Sirona
XRAY
+$76M
2
NVO
Novo Nordisk
NVO
+$43.1M
3
FRPT icon
Freshpet
FRPT
+$41.5M
4
SBUX icon
Starbucks
SBUX
+$31.9M
5
BMY icon
Bristol-Myers Squibb
BMY
+$30.3M

Top Sells

Rank Stock Value
1
SUPN icon
Supernus Pharmaceuticals
SUPN
+$79.6M
2
PTCT icon
PTC Therapeutics
PTCT
+$76M
3
GRFS
Grifois
GRFS
+$50.6M
4
STAA icon
STAAR Surgical
STAA
+$47.2M
5
TVTX icon
Travere Therapeutics
TVTX
+$40.5M

Sector Composition

Rank Sector Weight
1 Healthcare 31.9%
2 Technology 5.53%
3 Consumer Discretionary 5.27%
4 Communication Services 2.01%
5 Consumer Staples 1.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NPCE icon
76
Neuropace
NPCE
$465M
$13.4M 0.2%
1,298,000
+145,665
+13% +$1.37M
HUM icon
77
Humana
HUM
$42.8B
$13.4M 0.2%
+51,359
New +$13.5M
UBER icon
78
Uber
UBER
$140B
$11.8M 0.18%
120,581
+28,859
+31% +$2.7M
NTLA icon
79
Intellia Therapeutics
NTLA
$1.56B
$11.6M 0.17%
672,000
+22,000
+3% +$271K
EW icon
80
Edwards Lifesciences
EW
$51B
$11.4M 0.17%
+146,571
New +$11.5M
RDDT icon
81
Reddit
RDDT
$29.6B
$11.3M 0.17%
49,100
-3,900
-7% -$796K
ULTA icon
82
Ulta Beauty
ULTA
$23.2B
$11.1M 0.16%
20,266
+9,092
+81% +$4.66M
TOST icon
83
Toast
TOST
$20.3B
$10.4M 0.15%
286,036
+20,532
+8% +$891K
ARVN icon
84
Arvinas
ARVN
$550M
$10.2M 0.15%
1,200,000
+640,000
+114% +$4.85M
MGNX icon
85
MacroGenics
MGNX
$250M
$10M 0.15%
5,960,000
– –
LEN icon
86
Lennar Class A
LEN
$20.7B
$9.9M 0.15%
78,549
+38,528
+96% +$4.78M
BRBR icon
87
BellRing Brands
BRBR
$1.42B
$9.88M 0.15%
+271,935
New +$12.3M
FDMT icon
88
4D Molecular Therapeutics
FDMT
$541M
$9.52M 0.14%
1,096,000
+796,000
+265% +$4.76M
CNTA
89
DELISTED
Centessa Pharmaceuticals
CNTA
$9.17M 0.14%
378,000
-22,000
-6% -$391K
CHDN icon
90
Churchill Downs
CHDN
$6.09B
$9.06M 0.13%
93,429
-106,724
-53% -$11M
NUVB icon
91
Nuvation Bio
NUVB
$2.2B
$8.5M 0.13%
2,296,000
+1,796,000
+359% +$4.89M
BSX icon
92
Boston Scientific
BSX
$72B
$7.83M 0.12%
80,223
+5,223
+7% +$541K
H icon
93
Hyatt Hotels
H
$16.9B
$7.68M 0.11%
54,101
+19,322
+56% +$2.77M
ORLY icon
94
O'Reilly Automotive
ORLY
$76.2B
$7.59M 0.11%
70,396
-529
-0.7% -$53.2K
MCD icon
95
McDonald's
MCD
$195B
$7.22M 0.11%
23,770
-119,810
-83% -$36.5M
BBY icon
96
Best Buy
BBY
$17.1B
$7.19M 0.11%
95,066
+45,693
+93% +$3.28M
INGN icon
97
Inogen
INGN
$180M
$7.06M 0.1%
864,000
+200,000
+30% +$1.5M
ZURA icon
98
Zura Bio
ZURA
$541M
$6.75M 0.1%
1,560,000
+24,000
+2% +$43.2K
ANF icon
99
Abercrombie & Fitch
ANF
$4.93B
$6.66M 0.1%
+77,877
New +$7.27M
ANRO icon
100
Alto Neuroscience
ANRO
$1.13B
$6.58M 0.1%
1,636,000
+12,000
+0.7% +$39.8K
2 3
4
5 6

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Armistice Capital held 393 positions worth $6.74B, up 16% from $5.8B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Armistice Capital's Q3 2025 filing shows 188 new, 79 increased, 42 reduced and 65 closed positions. Its largest new stake was Novo Nordisk: 736,000 shares worth $40.8M. The largest sale was Supernus Pharmaceuticals, an estimated $79.6M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Armistice Capital's largest Q3 2025 buy was Novo Nordisk: 736,000 shares worth $40.8M.
  • Armistice Capital added most to Dentsply Sirona in Q3 2025, an estimated $76M increase.
  • Armistice Capital's biggest Q3 2025 reduction was Supernus Pharmaceuticals, cutting an estimated $79.6M.
  • Armistice Capital fully exited STAAR Surgical in Q3 2025, selling an estimated $47.2M.
  • Armistice Capital's ten largest holdings make up 64% of its $6.74B portfolio in Q3 2025.
  • Armistice Capital opened 188 new positions and closed 65 in Q3 2025.
  • Armistice Capital's portfolio value rose 16% quarter-over-quarter to $6.74B.

Based on Armistice Capital's 13F filing for Q3 2025, filed 17 Nov 2025.